Vitamin markets: Impact of new capacity of vit A from China yet to be seen
Vitamin A and E have both been very stable lately, at a high price level. It is expected that new capacity from China will come on the market for vitamin A, it remains to be seen what that potentially does to availability and market prices. Learn more in this week’s feed additives snapshot (week 49).
Vitamin E is expected to remain similar to the current situation on the short term, as the supply and demand is relatively balanced. Vitamin E buyers have a wait and see attitude and sellers are keen to get the price up.
Vitamin D3 remains firm and suppliers in China are very keen to raise the price further. Availability remains tight in most regions. Prices are stable to firm at a high price level.
Vitamin B3 is stable. Suppliers would like to see price increases but it is not supported yet by the market. Folic acid prices are shooting up. Prices have been stable at a relatively low level for a long time and now suppliers are successfully increasing prices.
In partnership with Feed Additive Prices
Vitamin E 50%
There is a tight balance between suppliers that are insisting on higher prices and buyers that have a wait-and-see attitude. The supply and demand ratio did not really change and is therefore pretty balanced at the moment. This has so far resulted in mostly stable prices in all regions, although stable at a high level. No short-term changes are expected to these dynamics. Right now the market is relatively quiet and contracted for Q4 and a good portion of Q1.
Vitamin A 1000
Prices have remained stable in the past few weeks in most regions. Although at a high price level still. Manufacturers and suppliers are keen to hold up these high prices. Buyers have a strong wait-and-see attitude and can still carry on with their current contracts into early Q1. New suppliers from China are becoming more visible now and new capacity can be expected in 2025. Buyers have already secured most of their Q4 and some Q1 needs.
Vitamin D3 500
The general tone is still tight, although no significantly higher prices are being paid. Some price increases are seen here and there. Recently, several manufacturers announced significant price increases. Most buyers are contracted ahead but will have to return to the market in late Q4 again if they do not cover anything right now for Q1. Q4 is mostly contracted and a small portion of Q1 as well. But in general, the market is in a wait-and-see mode, despite the currently firmer market.
Vitamin B2 80%
Prices in Europe remain firmer compared to earlier this year, as there are no Chinese sources available, and Western sources indicate to have limited material available. Prices FOB China and in the USA remain relatively stable and no nearby changes are expected. By now most of Q4 has been contracted and a good portion of Q1 as well.
D-Calpan
Relatively static market. Prices remain stable at a relatively low level and that goes for all regions. As there is an oversupply situation for this product, no signs of nearby change are expected. Q4 is mostly contracted and a good portion of Q1 as well.
Vitamin B3
Several suppliers have still stopped offering. There has been an ongoing desire by most manufacturers to increase prices and the raw material situation is said to be tight still in several cases. Yet, the market is not reacting to that in terms of booking more ahead or paying higher prices right now. It is still relatively quiet. Buyers had secured their Q4 and partially Q1 needs some time ago and after that, the market has gone quiet.
Biotin
No signs of any sort of change in the biotin market are seen or reported. Very static market at the moment. New additional production capacity in China has recently been announced for 2025. Q4 and a good portion of Q1 are contracted.
Vitamin C 35% mono
After some activity in the past few weeks and some firmer pricing, the market has become quiet again. Suppliers continue to insist on higher prices, therefore the current price level seems to be sticking. Q4 and a portion of Q1 have been contracted.
